img

News Topical, Digital Desk : Sanofi India, a pharmaceutical company listed on the BSE 1000, has made a significant announcement for its investors. In its meeting held on February 25, 2026, the board of directors recommended a 480% final dividend for the financial year ending December 31, 2025. The company disclosed this information in its exchange filing. 

When is the record date? 

The company declared a final dividend of 480 percent for the fiscal year ended December 31, 2025, meaning investors will receive ₹48 for each share with a face value of ₹10. The record date for this dividend is April 22nd. This means that only investors registered with the company by this date will be eligible for the dividend. The ex-dividend date is also April 22nd. This means that eligible investors must purchase Sanofi India shares before this date. 

It's worth noting that Sanofi India has consistently paid dividends to its shareholders. In 2025, the company paid two cash rewards – ₹75 in November and ₹117 in April. In 2024, Sanofi India paid two dividends – ₹117 in May and ₹50 in March.

What does the company do?

Sanofi India is a renowned R&D-based pharmaceutical company founded in 1956. It specializes in the areas of diabetes, cardiology, thrombosis, the central nervous system, and vaccines. As a subsidiary of France-based Sanofi, it has a strong manufacturing presence in Goa. Its portfolio includes a variety of high-quality products such as Lantus, Combiflam, and Allegra.


Read More: The government is introducing a ₹2 lakh crore credit guarantee scheme! Find out who will benefit from it.

--Advertisement--